Literature DB >> 24762209

Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.

Fa-Ling Wu1, Ke-Qing Shi, Yong-Ping Chen, Martin Braddock, Hai Zou, Ming-Hua Zheng.   

Abstract

Acute-on-chronic hepatitis B liver failure is a devastating condition that is associated with mortality rates of over 50% and is consequent to acute exacerbation of chronic hepatitis B in patients with previously diagnosed or undiagnosed chronic liver disease. Liver transplantation is the definitive treatment to lower mortality rate, but there is a great imbalance between donation and potential recipients. An early and accurate prognostic system based on the integration of laboratory indicators, clinical events and some mathematic logistic equations is needed to optimize treatment for patients. As parts of the scoring systems, the MELD was the most common and the donor-MELD was the most innovative for patients on the waiting list for liver transplantation. This review aims to highlight the various features and prognostic capabilities of these scoring systems.

Entities:  

Keywords:  Child-Turcotte-Pugh score; King’s College Criteria; acute-on-chronic hepatitis B liver failure; artificial neural network; donor-MELD; liver transplantation; model for end-stage liver disease; prognosis; regression scoring models; scoring systems; sequential organ failure assessment

Mesh:

Year:  2014        PMID: 24762209     DOI: 10.1586/17474124.2014.906899

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  9 in total

1.  Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure.

Authors:  Naijuan Yao; Yajuan He; Yuchao Wu; Fei Wang; Zhen Tian
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

2.  Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study.

Authors:  Sheng-Jie Wu; Hua-Dong Yan; Zai-Xing Zheng; Ke-Qing Shi; Fa-Ling Wu; Yao-Yao Xie; Yu-Chen Fan; Bo-Zhi Ye; Wei-Jian Huang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

3.  A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics.

Authors:  Yi Shen; Xulin Wang; Sheng Zhang; Gang Qin; Yanmei Liu; Yihua Lu; Feng Liang; Xun Zhuang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

4.  Association between plasma level of superoxide dismutase and survival of patients with acute-on-chronic liver failure.

Authors:  Zhen Tian; Naijuan Yao; Yuchao Wu; Fei Wang; Yingren Zhao
Journal:  BMC Gastroenterol       Date:  2022-02-05       Impact factor: 3.067

5.  Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients.

Authors:  Fei Wang; Minghui Tai; Yajuan He; Zhen Tian
Journal:  Int J Gen Med       Date:  2022-08-22

6.  Development of a FT3-related prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Jian Zhang; Yu Chen; Zhongping Duan
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 7.  Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.

Authors:  Wei-Lun Tsai; Wei-Chi Sun; Jin-Shiung Cheng
Journal:  Int J Mol Sci       Date:  2015-11-26       Impact factor: 5.923

8.  Conditional survival estimate of acute-on-chronic hepatitis B liver failure: a dynamic prediction based on a multicenter cohort.

Authors:  Ming-Hua Zheng; Sheng-Jie Wu; Ke-Qing Shi; Hua-Dong Yan; Hai Li; Gui-Qi Zhu; Yao-Yao Xie; Fa-Ling Wu; Yong-Ping Chen
Journal:  Oncotarget       Date:  2015-09-15

9.  TIPE2 mRNA Level in PBMCs Serves as a Novel Biomarker for Predicting Short-Term Mortality of Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Single-Center Study.

Authors:  Yu-Chen Fan; Na Wang; Yan-Yan Sun; Xiao-Yan Xiao; Kai Wang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.